These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21753879)

  • 1. Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.
    Almer G; Wernig K; Saba-Lepek M; Haj-Yahya S; Rattenberger J; Wagner J; Gradauer K; Frascione D; Pabst G; Leitinger G; Mangge H; Zimmer A; Prassl R
    Int J Nanomedicine; 2011; 6():1279-90. PubMed ID: 21753879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.
    Almer G; Summers KL; Scheicher B; Kellner J; Stelzer I; Leitinger G; Gries A; Prassl R; Zimmer A; Mangge H
    Int J Nanomedicine; 2014; 9():4211-22. PubMed ID: 25214785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
    Almer G; Frascione D; Pali-Schöll I; Vonach C; Lukschal A; Stremnitzer C; Diesner SC; Jensen-Jarolim E; Prassl R; Mangge H
    Mol Pharm; 2013 Jan; 10(1):175-86. PubMed ID: 23176185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 5. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions.
    Almer G; Saba-Lepek M; Haj-Yahya S; Rohde E; Strunk D; Fröhlich E; Prassl R; Mangge H
    Biologics; 2011; 5():95-105. PubMed ID: 22022204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
    Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
    Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
    Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
    Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
    Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
    Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
    van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
    Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiscale investigation of USPIO nanoparticles in atherosclerotic plaques and their catabolism and storage in vivo.
    Maraloiu VA; Appaix F; Broisat A; Le Guellec D; Teodorescu VS; Ghezzi C; van der Sanden B; Blanchin MG
    Nanomedicine; 2016 Jan; 12(1):191-200. PubMed ID: 26370708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.
    Bhavane R; Badea C; Ghaghada KB; Clark D; Vela D; Moturu A; Annapragada A; Johnson GA; Willerson JT; Annapragada A
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):285-94. PubMed ID: 23349231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice.
    Wen 文颂 S; Liu 柳东芳 DF; Liu 刘振 Z; Harris S; Yao 姚玉宇 YY; Ding 丁琪 Q; Nie 聂芳 F; Lu 卢瞳 T; Chen 陈华俊 HJ; An 安艳丽 YL; Zang 臧凤超 FC; Teng 滕皋军 GJ
    J Lipid Res; 2012 May; 53(5):829-838. PubMed ID: 22393161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque.
    van Bochove GS; Paulis LE; Segers D; Mulder WJ; Krams R; Nicolay K; Strijkers GJ
    Contrast Media Mol Imaging; 2011; 6(1):35-45. PubMed ID: 20882509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.
    Guo S; Shen S; Wang J; Wang H; Li M; Liu Y; Hou F; Liao Y; Bin J
    Theranostics; 2015; 5(4):418-30. PubMed ID: 25699100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.